Skip to main content

Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights

ZYCUBO® approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Therapeutics sold its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $205 million; Cyprium is also eligible to receive tiered royalties and up to approximately $128 million in aggregate sales milestones from Sentynl Therapeutics Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress remains eligible to receive up to an additional $4.8 million under a contingent value right (CVR), plus a 2.5% royalty on net sales of UNLOXCYT™ (cosibelimab-ipdl) MIAMI, March 31, 2026 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue,...

Continue reading

Workhorse Group Reports Fourth Quarter and Full Year 2025 Results

Revenue of $9.7 million in Q4 2025, up 64% year-over-year; full year revenue of $21.2 million, up 201% year-over-year On a pro forma basis, combined company revenue of $34.0 million for full year 2025, compared to $13.7 million in 2024, an increase of 149% Delivered 65 vehicles in Q4 2025 and 112 vehicles for full year 2025, compared to 46 vehicles in full year 2024 Combined delivered trucks surpassed 20 million real-world miles across more than 1,100 deployed vehicles Targeting $20 million in annualized cost synergies from merger integration as the company exits 2026 Announced a 140 kWh battery configuration of W56 step van in response to customer demandDETROIT, March 31, 2026 (GLOBE NEWSWIRE) — Workhorse Group Inc. (NASDAQ: WKHS) (“Workhorse” or the “Company”), a North American OEM and provider of all-electric trucks, step...

Continue reading

Nano Dimension Announces Financial Results for the Fourth Quarter and Full Year 2025

Full-Year 2025 revenue of $102.4 million, a 77.3% increase over the prior-year period  Company Continues to Drive Meaningful Cost Reductions Company Issues Full Year 2026 Financial Guidance Strategic Alternatives Review Advancing with Clear Path Forward Expected in Q2 WALTHAM, Mass., March 31, 2026 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension”, “Nano”, or the “Company”), a leader in digital manufacturing solutions, today announced financial results for the fourth quarter and full year ended December 31, 2025. The consolidated results incorporate the financial position and performance of Markforged Holding Corporation (“Markforged”) from the acquisition date of April 25, 2025. Desktop Metal, Inc. (“Desktop Metal”) was acquired by the Company on April 2, 2025. The results of Desktop Metal from April 2, 2025...

Continue reading

authID Reports Financial and Operating Results for the Fourth Quarter 2025

DENVER, March 31, 2026 (GLOBE NEWSWIRE) — authID® (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today reported financial and operating results for the Fourth Quarter and Fiscal Year ended December 31, 2025. Fourth Quarter 2025 vs. Fourth Quarter 2024 Financial SummaryTotal revenue for the quarter was $0.4 million, compared to $0.2 million a year ago. Operating expenses were $4.5 million, compared to $4.9 million a year ago. Net loss was $4.0 million, or $0.28 per share, compared to a loss of $4.6 million, or $0.42 per share a year ago. Adjusted EBITDA Loss of $3.0 million (non-GAAP measure as defined below), compared with $4.1 million a year ago. Gross bARR (Booked Annual Recurring Revenue) of $0.1 million (non-GAAP measure as defined below), compared...

Continue reading

TOMI Environmental Solutions, Inc. Reports Full Year 2025 Financial Results and Outlines Growth Initiatives

FREDERICK, Md., March 31, 2026 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology® (BIT™) platform, today announced financial results for the year ended December 31, 2025, and provided an update on strategic initiatives designed to drive long-term growth. 2025 Highlights:Recap of 2025: TOMI made meaningful strides across multiple strategic priorities. We continued to strengthen our government relationships, highlighted by our selection by NASA for a biosecurity operation for our reliability in mission-critical environments. Commercially, we announced several new customer wins across global CDMOs, leaders in eye health, and prestigious university research groups. In parallel, regulatory and...

Continue reading

Societe Generale SFH: Availability of the Annual Financial Report for 2025

SOCIETE GENERALE SFH: AVAILABILITY OF THE ANNUAL FINANCIAL REPORT FOR 2025 Regulated Information Paris, 31 March 2026 Societe Generale SFH (“Société de Financement de l’Habitat”, Home Loans SFH) hereby informs the public that the Annual Financial Report for the period ended 31 December 2025 has been filed with the French financial markets authority (The Autorité des Marchés Financiers – AMF) on 31 March 2026. This document, available in French only, is made available to the public, free of charge, in accordance with the conditions provided for by the regulations in force and may be consulted in the “Societe Generale Home Loans SFH / Regulated information” section of the Societe Generale group’s website and on the AMF’s website. Press contacts:Jean-Baptiste Froville_+33 1 58 98 68 00_ jean-baptiste.froville@socgen.com Fanny Rouby_+33...

Continue reading

WINFARM reports a strong improvement in its 2025 full-year results.

PRESS RELEASE Loudéac, 31 March 2026WINFARM reports a strong improvement in its 2025 full-year resultsEBITDA of €5.3 million (3.6% of revenue), i.e. multiplied by a factor of 4 almost Cash flow generation of €1.4 million Reduction in net financial debt of €7 millionOutlook for 2026Continued cash generation and debt reduction driven by a further improvement in EBITDAWINFARM (ISIN: FR0014000P11 – ticker: ALWF), the leading French player in distance-selling of products and solutions for the agricultural industry, today published its consolidated results for the 2025 financial year, as approved by the Board of Directors at its meeting of 31 March 2026 and audited by the statutory auditors. The certification reports are currently being drawn up. The consolidated financial statements for the 2025 financial year are available...

Continue reading

Societe Generale SCF: Availability of the Annual Financial Report for 2025

SOCIETE GENERALE SCF: AVAILABILITY OF THE ANNUAL FINANCIAL REPORT FOR 2025 Regulated Information Paris, 31 March 2026 Societe Generale SCF (“Société de Crédit Foncier”, Public Sector Loans) hereby informs the public that the Annual Financial Report for the period ended 31 December 2025, has been filed with the French financial markets authority (The Autorité des Marchés Financiers – AMF) on 31 March 2026. This document, available in French only, is made available to the public, free of charge, in accordance with the conditions provided for by the regulations in force and may be consulted in the “Societe Generale Public Sector Loans SCF / Regulated information” section of the Societe Generale group’s website and on the AMF’s website. Press contacts:Jean-Baptiste Froville_+33 1 58 98 68 00_ jean-baptiste.froville@socgen.com Fanny Rouby_+33...

Continue reading

Proactis SA 12 months revenue 31 January 2026

Proactis SA Announces Financial Information for the year ended 31 January 2026 Paris – March 31, 2026 – Proactis SA (Euronext: PROAC), a leading provider of comprehensive spend management and business process collaboration solutions, today announces financial information for the year ended 31 January 2026, in accordance with the “European Transparency Obligations Directive” financial disclosure requirements. Financial datain € million     Year ended 31 Jan 2026   Year ended 31 Jan 2025     % Change2026/2025(*)                 Consolidated Operational Revenue     4.7   5.5     (15) %SaaS (**)     4.4   5.0     (13) %Services     0.3   0.4     (37) %                 Management fees     4.6   3.8     21 %                 Consolidated Revenue     9.3   9.3     0 %(unaudited Figures)                (*) Percentages...

Continue reading

Fluxys Belgium – Regulated information: 2025 annual results

Overview of 2025 annual resultsConsolidated net profit was EUR 74.9 million (EUR 82.1 million in 2024) Allocation of profit proposal to the Annual General Meeting of 12 May 2026: gross dividend of EUR 1.40 per share (2025: EUR 1.40 per share) Large flows to Germany and the Netherlands continue Additional transmission capacity from the west under construction The number of loaded LNG trucks in Zeebrugge is growing 73% more bio-LNG at the Zeebrugge terminal Start of construction on initial hydrogen and CO2 infrastructure Fluxys c-grid appointed as CO2 network operator in Wallonia and Flanders Boosting Belgium as a CO2 hub in North-West Europe Strong results across multiple ESG objectives 102 new colleagues hired  Key financial dataIncome statement (in thousands of EUR) 31/12/2025 31/12/2024Operating revenue 650,453 608,789EBITDA* 320,111 302,283EBIT* 133,916 133,931Net...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.